STUDY OF BIOLOGICAL PROPERTIES OF HIV-1 VARIANTS RESISTANT TO ANTIRETROVIRALPREPARATIONS
- Authors: Nikonorova Y.V1, Unagaeva NV1, Bogachev VV1, Baryshev PB1, Meshcheryakova Y.V1, Chernousova NY.1, Gashnikova NM1, Nikonorova Y.V2, Unagaeva NV2, Bogachev VV2, Baryshev PB2, Meschseryakova Y.V3, Chernousova NY.3, Gashnikova NM2
-
Affiliations:
- State Scientific Centre of Virology and Biotechnology Vector
- Novosibirsk Regional Centre of Prophylaxis andControl of AIDS and Infectious Diseases, Koltsovo, Novosibirsk region, Russia
- Issue: Vol 89, No 6 (2012)
- Pages: 52-56
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.12.2012
- URL: https://microbiol.crie.ru/jour/article/view/13719
- ID: 13719
Cite item
Full Text
Abstract
courses. Analysis of genetic and replicative properties of the separated isolates, study of pol gene mutation
stability sustentation that is responsible for the emergence of drug resistance. Materials and methods. HIV
isolate separation was carried out by co-cultivation of peripheral blood mononuclears of HIV infected patients
with previously stimulated phytohemagglutinin cells of healthy donors. Virus replication was evaluated by
the level of p24 virus specific protein accumulation determined in enzyme immunoassay. HIV-1 subtype
identification, detection of HIV-1 genome mutations were carried out by pol gene nucleotide sequence determination
and subsequent analysis of the data obtained - by using specialized program resources. Results.
14 infectious HIV-1 subtype A, B and CRF02_AG isolates were separated containing various sets of mutations
determining resistance to widely used in clinical practice nucleoside and non-nucleoside reverse transcriptase
inhibitors. Comparative analysis of mutation specter detected in HIV-1 variant genomes before
isolation and after their cultivation showed that during HIV-1 cultivation in mononuclear blood cells without
the addition of antiretroviral preparations not only partial loss of mutations is observed but also emergence
of new drug resistance mutations; and most of the mutation causing virus resistance to antiretroviral preparations
remain. Conclusion. High reproductive properties of the HIV-1 isolates separated allow to use them
to evaluate effectiveness of the drugs being developed against HIV-1 resistant to antiretroviral preparations.
About the authors
Yu V Nikonorova
N V Unagaeva
V V Bogachev
P B Baryshev
Yu V Meshcheryakova
N Ya Chernousova
N M Gashnikova
Yu V Nikonorova
State Scientific Centre of Virology and Biotechnology VectorState Scientific Centre of Virology and Biotechnology Vector
N V Unagaeva
State Scientific Centre of Virology and Biotechnology VectorState Scientific Centre of Virology and Biotechnology Vector
V V Bogachev
State Scientific Centre of Virology and Biotechnology VectorState Scientific Centre of Virology and Biotechnology Vector
P B Baryshev
State Scientific Centre of Virology and Biotechnology VectorState Scientific Centre of Virology and Biotechnology Vector
Yu V Meschseryakova
Novosibirsk Regional Centre of Prophylaxis andControl of AIDS and Infectious Diseases, Koltsovo, Novosibirsk region, RussiaNovosibirsk Regional Centre of Prophylaxis andControl of AIDS and Infectious Diseases, Koltsovo, Novosibirsk region, Russia
N Ya Chernousova
Novosibirsk Regional Centre of Prophylaxis andControl of AIDS and Infectious Diseases, Koltsovo, Novosibirsk region, RussiaNovosibirsk Regional Centre of Prophylaxis andControl of AIDS and Infectious Diseases, Koltsovo, Novosibirsk region, Russia
N M Gashnikova
State Scientific Centre of Virology and Biotechnology VectorState Scientific Centre of Virology and Biotechnology Vector
References
- Coffin J.M. HIV population dynamics in vivo: implications for genetic variation: pathogenesis, and therapy. Science. 1995, 267: 483-489.
- Cong M., García-Lerma J. G., Heneine W. The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions. J. Virology. 2007, 81 (6): 3037-3041.
- Demeter L. M., Dykes C. Clinical significance of human immunodeficiency virus type 1 replication fitness. Clin. Microbiol. Rev. 2007, 20: 550-578.
- Dudley J., Nei M., Kumar S., Tamura K. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24: 1596-1599.
- http://hivdb6.stanford.edu.
- Schuitemaker H., Kootstra N.A. Isolation, propagation, and titration of human immunodeficiency virus type 1 from peripheral blood of infected individuals. Human Retrovir. Protocols: Virol. Mol. Biol. 2005, 304: 17-24.